CooperSurgical is the leading company dedicated to providing medical devices and procedure solutions that improve health care delivery to women regardless of clinical setting. The company is fostering that position through expansion of its core businesses and introduction of advanced technology-based products which aid clinicians in the management and treatment of commonly seen conditions.CooperSurgical products fall into three main segments based on the point of health care delivery: Hospital, Office and Clinic.

For 50 years, Cordis Corporation, a Johnson & Johnson company, has pioneered less invasive treatments for vascular disease. Technological innovation and a deep understanding of the medical marketplace and the needs of patients have made Cordis the world's leading developer and manufacturer of breakthrough stents, catheters and guidewires for interventional medicine, minimally invasive computer-based imaging, and electrophysiology.Today, approximately 5,000 Cordis employees worldwide share a strong commitment to continue the Company's groundbreaking work in the fight against vascular disease.

Corin Group does its best work right at the literal crux of arthritis problems. The company designs and manufactures reconstructive orthopedic devices often used in joint replacement procedures. In addition to replacement ankles, hips, knees, and spinal implants, Corin is also working on computerized surgical systems to assist doctors during joint replacement surgery and other procedures. The company has nine subsidiaries based outside the UK, including in Austria, Japan, and Spain. Corin Group sells its products directly and through distributors in about 70 countries. The company -- which operates one main manufacturing and supply center in the UK -- was established in 1985 and went public in 2002.

CRH Medical Corporation specializes in the treatment of hemorrhoids utilizing its proprietary CRH O’Regan System which includes CRH’s patented proprietary technology and treatment protocols. CRH’s single use, disposable, hemorrhoid treatment technology is safe and highly effective in treating hemorrhoids. CRH employs two commercialization strategies: firstly, it operates Centers for Colorectal Health facilities (the “Centers”) in the United States specializing in the treatment of hemorrhoids and related anal rectal disorders. The Company currently operates ten Centers geographically dispersed through the U.S. Secondly, CRH distributes its hemorrhoid banding technology, treatment protocols, operational and marketing expertise as a complete, turn key package, directly to its partner physicians, referred to as the “Partnership Program.”

Criticare Systems helps hospitals keep better tabs on their patients. Instruments and sensors made by the company monitor the vital signs and anesthetic levels of patients undergoing surgery or confined to intensive care. Its products also provide readings for electrocardiograms and monitor oxygen saturation, carbon dioxide levels, blood pressure, temperature, heart rate, and respiration rate. Criticare's VitalView telemetry system allows one nurse to keep tabs on more than a dozen patients from a single location. The company also makes reusable pulse oximetry sensors for use with its equipment. The company is a subisidiary of India-based manufacturer Opto Circuits.

CryoCor has found that being cold-hearted can be helpful sometimes. The company makes a minimally-invasive disposable catheter and cooling console to treat common cardiac arrhythmias (heart rhythm disorders) known as atrial fibrillation and atrial flutter. Unlike commonly used heat-based cardiac ablation, its cryoablation system inserts a catheter into a blood vessel connected with the heart and uses extreme cold to destroy targeted cells and help the heart function normally. The cryoablation system is marketed for certain indications in the US and Europe. CryoCor is a part of the cardiac rhythm management division of parent Boston Scientific.

CryoLife preserves lives by conserving the tissues that sustain it. The company takes human heart valves and blood vessels from deceased volunteer donors, processes them, and stores them in liquid nitrogen freezers (a process called cryopreservation). It then ships them to surgeons nationwide, who implant them during cardiac and vascular repair procedures. For some preserved tissue, the company uses its proprietary SynerGraft technology, which reduces the presence of donor cells and makes the tissue more compatible with the recipient. CryoLife also develops implantable biomaterials, including BioGlue, an adhesive used to seal internal surgical wounds.

CV Laser Pty Ltd T/as CustomVisTM is an innovative company in the laser vision correction industry, with a focus on "custom surgery." The company's flagship product, the PULZARTM Z1 is a solid state refractive laser that is designed specifically for custom surgery, permitting an accurate approach to correcting both standard and non-standard vision disorders. The PULZARTM Z1 system uses a patented solid-state technology, permitting surgeons to treat more patients, with greater accuracy, and also to treat patients that other technologies may be unable to treat.

Cutera has a handle on hairy situations and a firm plan for flabby faces. The firm makes lasers for medical and aesthetic use in doctors' offices and spas. Its FDA-approved devices are marketed under the names CoolGlide, Solera, and Xeo and are used for hair removal and treatments to reduce pigmented lesions (age and sun spots), wrinkles, and veins. Its Titan line of products uses deep tissue heating to firm up saggy skin. The company markets its products through a direct sales force and a distributor (PSS World Medical) in the US and relies on a small sales group and distributors in more than 30 other countries.

Cyberonics makes the first medical device to be cleared by the FDA for treating epilepsy. The company's VNS Therapy System is a pacemaker-like device implanted under the collarbone with a lead attached to the vagus nerve in the neck. The device delivers intermittent signals to the brain, dubbed vagus nerve stimulation (VNS), to control epileptic seizures. The signals can be programmed by a physician using a computer, and patients can stop or start signals with a hand-held magnet. The VNS system is also used for treatment-resistant depression, and it is being studied for conditions such as bulimia and Alzheimer's disease. In addition to the US, Cyberonics markets the system in about 70 countries around the globe.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.